title: Severe thromboembolic complications associated with the administration of intravenous immunoglobulins.
authors: M
authors: M
authors: Gómez Pérez
authors: M
authors: M
authors: Hernández Segurado
authors: M
authors: M
authors: Bonilla Porras
authors: J
authors: J
authors: Bécares Martínez
mesh_terms: D000369:Aged, 80 and over; D001037:Aphasia / Q000209:etiology; D002545:Brain Ischemia / Q000209:etiology*; D003131:Combined Modality Therapy; D005060:Europe / Q000453:epidemiology; D017809:Fatal Outcome; D005260:Female; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000008:administration & dosage / Q000009:adverse effects*; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007262:Infusions, Intravenous; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000188:drug therapy / Q000209:etiology*; D005996:Nitroglycerin / Q000627:therapeutic use; D010291:Paresis / Q000209:etiology; D011241:Prednisone / Q000627:therapeutic use; D016553:Purpura, Thrombocytopenic, Idiopathic / Q000150:complications / Q000188:drug therapy / Q000628:therapy; D056737:Safety-Based Drug Withdrawals; D013923:Thromboembolism / Q000453:epidemiology / Q000209:etiology
chemical_list: D016756:Immunoglobulins, Intravenous; D007166:Immunosuppressive Agents; D005996:Nitroglycerin; D011241:Prednisone